Brain, Vol. 126, No. 5, 1231-1240,
May 2003
© 2003 Guarantors of Brain
doi: 10.1093/brain/awg101
Executive and visuospatial deficits in patients with chronic progressive external ophthalmoplegia and KearnsSayre syndrome
1 Department of Psychiatry and 2 Department of Neurology, University of Bonn, Germany
Correspondence to: PD Dr Michael Wagner, Neuropsychology Laboratory, Department of Psychiatry, University Hospital of Bonn, Sigmund-Freud-Str. 25, 53105 Bonn, Germany E-mail: michael.wagner{at}ukb.uni-bonn.de*These two authors contributed equally to this work
Although neuropsychological deficits have been reported in mitochondrial cytopathies, patients with chronic progressive external ophthalmoplegia (CPEO) or KearnsSayre syndrome (KSS) have not been studied systematically using a comprehensive test battery. The aim of our study was to assess the range and extent of putative cognitive dysfunction in 22 patients with CPEO or KSS, and to compare cognitive performance of patients with healthy control subjects matched for age, sex and years of education. Genetic analysis of skeletal muscle tissue from 22 patients with CPEO or KSS included screening for mitochondrial DNA (mtDNA) point mutations (3243/8344) and mtDNA deletions. All patients were examined by a neuropsychological test battery covering verbal skills, verbal and visual memory, visuo-spatial perception, visual construction, attention, abstraction and flexibility, and Quality of Life. Molecular genetic analysis of mtDNA revealed single large-scale deletions in 15 out of 22 patients and the tRNA (Leu) A3243G point mutation in two out of 22 patients. In five out of 22 patients none of the frequently encountered mtDNA mutations could be detected. Neuropsychological testing did not reveal general intellectual deterioration, but specific cognitive deficits, particularly in visual construction, attention and abstraction/flexibility. Subgroup analysis of 15 patients with mtDNA deletions showed similar results when compared with the full group. In our series of patients with CPEO or KSS neuropsychological testing did not reveal signs that would suggest general intellectual decline or dementia, but provided evidence of specific focal neuropsychological deficits, suggesting particular impairment of visuospatial perception associated to parieto-occipital lobes and executive deficits associated to the prefrontal cortex.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L.J.A.M. Jacobs, G. de Wert, J.P.M. Geraedts, I.F.M. de Coo, and H.J.M. Smeets The transmission of OXPHOS disease and methods to prevent this Hum. Reprod. Update, March 1, 2006; 12(2): 119 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Minnerop, C Kornblum, A Y Joe, K Tatsch, W S Kunz, T Klockgether, U Wullner, and M J Reinhardt Dopamine transporter SPECT in patients with mitochondrial disorders J. Neurol. Neurosurg. Psychiatry, January 1, 2005; 76(1): 118 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Michaelides and A T Moore The genetics of strabismus J. Med. Genet., September 1, 2004; 41(9): 641 - 646. [Abstract] [Full Text] [PDF] |
||||


